| Health / Medical Topics |
BMS-354825
A drug used to treat certain types of chronic myeloid leukemia and acute lymphoblastic leukemia. BMS-354825 is also being studied in the treatment of certain other blood diseases and types of cancer. BMS-354825 binds to and blocks BCR-ABL and other proteins that help cancer cells grow. It is a type of tyrosine kinase inhibitor. Also called dasatinib and Sprycel. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors…
An orally available, C-4 methyl carbonate analog of paclitaxel with potential antineoplastic activity. Like paclitaxel, BMS-275183 binds to tubulin and stabilizes microtubules,…
A drug used to treat metastatic or locally advanced breast cancer that has not improved after treatment with certain other anticancer…
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called farnesyltransferase inhibitors. …
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called taxane analogs. …
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called mitotic inhibitors. …
